Role of tumor-associated macrophages in the angiogenesis of well-differentiated hepatocellular carcinoma: Pathological-radiological correlation

Oncology Reports

Volumn 31, Issue 6, 2014, Pages 2499-2505

  Fujita, Nobuhiro ^a   Nishie, Akihiro ^a   Aishima, Shinichi ^a   Kubo, Yuichiro ^a   Asayama, Yoshiki ^a   Ishigami, Kousei ^a   Kakihara, Daisuke ^a   Ushijima, Yasuhiro ^a   Takayama, Yukihisa ^a   Shirabe, Ken ^a   Oda, Yoshinao ^a   Honda, Hiroshi ^a  

^a KYUSHU UNIVERSITY   (Japan)

Author keywords

Computed tomography hepatic angiography; Hepatocellular carcinoma; M2 macrophage; Tumor angiogenesis; Tumor associated macrophage

Indexed keywords

CD163 ANTIGEN; CD68 ANTIGEN; CD34 ANTIGEN; CD68 ANTIGEN, HUMAN; DIFFERENTIATION ANTIGEN; LEUKOCYTE ANTIGEN;

ADULT; AGED; ANGIOGENESIS; ANTIGEN FUNCTION; ARTICLE; CANCER STAGING; CAPILLARY DENSITY; COMPUTER ASSISTED TOMOGRAPHY; CORRELATIONAL STUDY; DISEASE ASSOCIATION; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LIVER ANGIOGRAPHY; LIVER CELL CARCINOMA; MACROPHAGE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; TUMOR ASSOCIATED LEUKOCYTE; TUMOR DIFFERENTIATION; CELL DIFFERENTIATION; GENETICS; LIVER TUMOR; METABOLISM; MIDDLE AGED; NEOVASCULARIZATION (PATHOLOGY); PATHOLOGY; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; ANTIGENS, CD; ANTIGENS, CD34; ANTIGENS, DIFFERENTIATION, MYELOMONOCYTIC; CARCINOMA, HEPATOCELLULAR; CELL DIFFERENTIATION; FEMALE; HUMANS; LIVER NEOPLASMS; MACROPHAGES; MALE; MIDDLE AGED; NEOVASCULARIZATION, PATHOLOGIC; TOMOGRAPHY, X-RAY COMPUTED;

EID: 84902209202     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or.2014.3138     Document Type: Article

References (35)

1. Okuda K: Hepatocellular carcinoma: clinicopathological aspects. J Gastroenterol Hepatol 12: S314-S318, 1997.
2. Bosch FX, Ribes J, Díaz M and Cléries R: Primary liver cancer: worldwide incidence and trends. Gastroenterology 127: S5-S16, 2004. (Pubitemid 39423365)
3. Llovet JM, Burroughs A and Bruix J: Hepatocellular carcinoma. Lancet 362: 1907-1917, 2003. (Pubitemid 37518510)
4. Feitelson MA, Sun B, Satiroglu Tufan NL, Liu J, Pan J and Lian Z: Genetic mechanisms of hepatocarcinogenesis. Oncogene 21: 2593-2604, 2002. (Pubitemid 34438112)
5. Kudo M: Multistep human hepatocarcinogenesis: correlation of imaging with pathology. J Gastroenterol 44 (Suppl 19): 112-118, 2009.
6. Ueda K, Terada T, Nakanuma Y and Matsui O: Vascular supply in adenomatous hyperplasia of the liver and hepatocellular carcinoma: a morphometric study. Hum Pathol 23: 619-626, 1992.
7. Fujita N, Aishima S, Iguchi T, et al: Down-regulation of artery in moderately differentiated hepatocellular carcinoma related to tumor development. Hum Pathol 41: 838-847, 2010.
8. Tajima T, Honda H, Taguchi K, et al: Sequential hemodynamic change in hepatocellular carcinoma and dysplastic nodules: CT angiography and pathologic correlation. AJR Am J Roentgenol 178: 885-897, 2002. (Pubitemid 34250225)
9. Hayashi M, Matsui O, Ueda K, et al: Correlation between the blood supply and grade of malignancy of hepatocellular nodules associated with liver cirrhosis: evaluation by CT during intraarterial injection of contrast medium. AJR Am J Roentgenol 172: 969-976, 1999. (Pubitemid 29505622)
10. Biswas SK and Mantovani A: Macrophage plasticity and interaction with lymphocyte subsets: cancer as a paradigm. Nat Immunol 11: 889-896, 2010.
11. Martinez FO, Gordon S, Locati M and Mantovani A: Transcriptional profiling of the human monocyte-to-macrophage differentiation and polarization: new molecules and patterns of gene expression. J Immunol 177: 7303-7311, 2006. (Pubitemid 44715100)
12. Lewis CE and Pollard JW: Distinct role of macrophages in different tumor microenvironments. Cancer Res 66: 605-612, 2006. (Pubitemid 43165918)
13. Shirabe K, Mano Y, Muto J, et al: Role of tumor-associated macrophages in the progression of hepatocellular carcinoma. Surg Today 42: 1-7, 2012.
14. Leek RD, Lewis CE, Whitehouse R, Greenall M, Clarke J and Harris AL: Association of macrophage infiltration with angiogenesis and prognosis in invasive breast carcinoma. Cancer Res 56: 4625-4629, 1996. (Pubitemid 26338061)
15. Koide N, Nishio A, Sato T, Sugiyama A and Miyagawa S: Significance of macrophage chemoattractant protein-1 expression and macrophage infiltration in squamous cell carcinoma of the esophagus. Am J Gastroenterol 99: 1667-1674, 2004. (Pubitemid 39237489)
16. Hanada T, Nakagawa M, Emoto A, Nomura T, Nasu N and Nomura Y: Prognostic value of tumor-associated macrophage count in human bladder cancer. Int J Urol 7: 263-269, 2000. (Pubitemid 30440592)
17. Lissbrant IF, Stattin P, Wikstrom P, Damber JE, Egevad L and Bergh A: Tumor associated macrophages in human prostate cancer: Relation to clinicopathological variables and survival. Int J Oncol 17: 445-451, 2000.
18. Imai Y, Murakami T, Yoshida S, et al: Superparamagnetic iron oxide-enhanced magnetic resonance images of hepatocellular carcinoma: correlation with histological grading. Hepatology 32: 205-212, 2000. (Pubitemid 30614651)
19. Theise ND, Ishak KG, Kojiro M, et al: Hepatocellular carinoma. In: World Health Organization Classification of the Digestive System. Bosman FT, Carneiro F, Hruban RH and Theise ND (eds). IARC Press, Lyon, pp205-216, 2010.
20. International Consensus Group for Hepatocellular Neoplasia: Pathologic diagnosis of early hepatocellular carcinoma: a report of theInternational Consensus Group for Hepatocellular Neoplasia. Hepatology 49: 658-664, 2009.
21. Weidner N, Semple JP, Welch WR and Folkman J: Tumor angiogenesis and metastasis - correlation in invasive breast carcinoma. N Engl J Med 324: 1-8, 1991.
22. Hasita H, Komohara Y, Okabe H, et al: Significance of alternatively activated macrophages in patients with intrahepatic cholangiocarcinoma. Cancer Sci 101: 1913-1919, 2010.
23. Fujiwara Y, Komohara Y, Ikeda T and Takeya M: Corosolic acid inhibits glioblastoma cell proliferation by suppressing the activation of signal transducer and activator of transcription-3 and nuclear factor-kappa B in tumor cells and tumor-associated macrophages. Cancer Sci 102: 206-211, 2011.
24. Komohara Y, Ohnishi K, Kuratsu J and Takeya M: Possible involvement of the M2 anti-inflammatory macrophage phenotype in growth of human gliomas. J Pathol 216: 15-24, 2008.
25. Yancopoulos GD, Davis S, Gale NW, Rudge JS, Wiegand SJ and Holash J: Vascular-specific growth factors and blood vessel formation. Nature 407: 242-248, 2000.
26. Holash J, Wiegand SJ and Yancopoulos GD: New model of tumor angiogenesis: dynamic balance between vessel regression and growth mediated by angiopoietins and VEGF. Oncogene 18: 5356-5362, 1999. (Pubitemid 29462372)
27. El-Assal ON, Yamanoi A, Soda Y, et al: Clinical significance of microvessel density and vascular endothelial growth factor expression in hepatocellular carcinoma and surrounding liver: possible involvement of vascular endothelial growth factor in the angiogenesis of cirrhotic liver. Hepatology 27: 1554-1562, 1998. (Pubitemid 28264678)
28. Wada H, Nagano H, Yamamoto H, et al: Expression pattern of angiogenic factors and prognosis after hepatic resection in hepatocellular carcinoma: importance of angiopoietin-2 and hypoxia-induced factor-1α. Liver Int 26: 414-423, 2006.
29. Mitsuhashi N, Shimizu H, Ohtsuka M, et al: Angiopoietins and Tie-2 expression in angiogenesis and proliferation of human hepatocellular carcinoma. Hepatology 37: 1105-1113, 2003. (Pubitemid 36538687)
30. de Visser KE, Eichten A and Coussens LM: Paradoxical roles of the immune system during cancer development. Nat Rev Cancer 6: 24-37, 2006. (Pubitemid 43053650)
31. Mantovani A, Sozzani S, Locati M, Allavena P and Sica A: Macrophage polarization: tumor-associated macrophages as a paradigm for polarized M2 mononuclear phagocytes. Trends Immunol 23: 549-555, 2002. (Pubitemid 35223554)
32. Murdoch C, Giannoudis A and Lewis CE: Mechanisms regulating the recruitment of macrophages into hypoxic areas of tumors and other ischemic tissues. Blood 104: 2224-2234, 2004. (Pubitemid 39331817)
33. Kanematsu M, Osada S, Amaoka N, et al: Expression of vascular endothelial growth factor in hepatocellular carcinoma and the surrounding liver: correlation with angiographically assisted CT. AJR Am J Roentgenol 183: 1585-1593, 2004. (Pubitemid 44210524)
34. Kanematsu M, Osada S, Amaoka N, et al: Expression of vascular endothelial growth factor in hepatocellular carcinoma and the surrounding liver and correlation with MRI findings. AJR Am J Roentgenol 184: 832-841, 2005. (Pubitemid 43899509)
35. Zhang W, Zhu XD, Sun HC, et al: Depletion of tumor-associated macrophages enhances the effect of sorafenib in metastatic liver cancer models by antimetastatic and antiangiogenic effects. Clin Cancer Res 16: 3420-3430, 2010.